Stockreport

AbbVie reports positive results from Rinvoq versus Dupixent study [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF dermatitis than Sanofi ( SNY ) and Regeneron's ( REGN ) Dupixent in adults and adolescents. The Phase 3b/4 study, called LEVEL UP, found that 19.9% of Recommended Fo [Read more]